Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15

Author： Wagner H-j   Sili U   Gahn B   Vigouroux S   Huls Mh   Xie W   Vignali D   Brenner Mk   Heslop He   Rooney Cm  

Publisher： Ashgate Publishing Ltd

ISSN： 1465-3249

Source： Cytotherapy, Vol.5, Iss.3, 2003-01, pp. : 231-240

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Persistence makes perfect: the benefits of IL-2 in adoptive immunotherapy

By Rizzuto GA   Wolchok JD  

Cytotherapy, Vol. 7, Iss. 5, 2005-11 ,pp. : 391-392

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials

By Digiusto Dl   Cooper Ljn  

Cytotherapy, Vol. 9, Iss. 7, 2007-01 ,pp. : 613-629

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Fate and function of anti-CD3/CD28-activated T cells following adoptive transfer: IL-2 promotes development of anti-tumor memory T cells in vivo

By Hughes DPM   Baskar D   Urban FA   Friedman MS   Braun TM   McDonagh KT  

Cytotherapy, Vol. 7, Iss. 5, 2005-11 ,pp. : 396-407

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy

By Besser Mj   Schallmach E.   Oved K.   Treves Aj   Markel G.   Reiter Y.   Schachter J.  

Cytotherapy, Vol. 11, Iss. 2, 2009-04 ,pp. : 206-217

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma

By Wu Jy   Ernstoff Ms   Hill Jm   Cole B   Meehan Kr  

Cytotherapy, Vol. 8, Iss. 2, 2006-05 ,pp. : 141-148

Ashgate Publishing Ltd

Access to resources Recommend Favorite